BCSSX | NRGSX | BCSSX / NRGSX | |
Total Expense Ratio | 1.12 | 0.74 | 151% |
Annual Report Gross Expense Ratio | 1.12 | 0.74 | 151% |
Fund Existence | 14 years | 13 years | - |
Gain YTD | -10.233 | -3.902 | 262% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 670M | 8.69B | 8% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | -34.57 | -10.12 | 342% |
Returns for 3 years | -36.96 | 5.90 | -626% |
Returns for 5 years | -63.59 | -2.32 | 2,739% |
Returns for 10 years | -36.25 | 10.24 | -354% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TGDVX | 17.60 | 0.07 | +0.40% |
TCW Relative Value Large Cap N | |||
GSVPX | 16.76 | 0.05 | +0.30% |
Goldman Sachs Small/Mid Cap Equity P | |||
RLBBX | 38.66 | 0.03 | +0.08% |
American Funds American Balanced R2 | |||
FCVAX | 19.12 | N/A | N/A |
Fidelity Advisor Small Cap Value A | |||
OAZEX | 22.30 | -0.09 | -0.40% |
Oakmark International Small Cap R6 |